{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:00:57Z","timestamp":1786125657472,"version":"build-2736575974"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosurg.","NEUROS"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Cerebral cavernous angioma (CA) is a capillary microangiopathy predisposing more than a million Americans to premature risk of brain hemorrhage. CA with recent symptomatic hemorrhage (SH), most likely to re-bleed with serious clinical sequelae, is the primary focus of therapeutic development. Signaling aberrations in CA include proliferative dysangiogenesis, blood-brain barrier hyperpermeability, inflammatory\/immune processes, and anticoagulant vascular domain. Plasma levels of molecules reflecting these mechanisms and measures of vascular permeability and iron deposition on magnetic resonance imaging are biomarkers that have been correlated with CA hemorrhage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To optimize these biomarkers to accurately diagnose cavernous angioma with symptomatic hemorrhage (CASH), prognosticate the risk of future SH, and monitor cases after a bleed and in response to therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Additional candidate biomarkers, emerging from ongoing mechanistic and differential transcriptome studies, would further enhance the sensitivity and specificity of diagnosis and prediction of CASH. Integrative combinations of levels of plasma proteins and characteristic micro-ribonucleic acids may further strengthen biomarker associations. We will deploy advanced statistical and machine learning approaches for the integration of novel candidate biomarkers, rejecting noncorrelated candidates, and determining the best clustering and weighing of combined biomarker contributions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>EXPECTED OUTCOMES<\/jats:title>\n                    <jats:p>With the expertise of leading CA researchers, this project anticipates the development of future blood tests for the diagnosis and prediction of CASH to clinically advance towards precision medicine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION<\/jats:title>\n                    <jats:p>The project tests a novel integrational approach of biomarker development in a mechanistically defined cerebrovascular disease with a relevant context of use, with an approach applicable to other neurological diseases with similar pathobiologic features.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuros\/nyaa478","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T15:14:46Z","timestamp":1601565286000},"page":"686-697","source":"Crossref","is-referenced-by-count":28,"title":["A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH)"],"prefix":"10.1227","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5893-9315","authenticated-orcid":false,"given":"Romuald","family":"Girard","sequence":"first","affiliation":[{"name":"Neurovascular Surgery Program, Department of Surgery, Section of Neurosurgery, University of Chicago Medicine and Biological Sciences, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Neurovascular Surgery Program, Department of Surgery, Section of Neurosurgery, University of Chicago Medicine and Biological Sciences, Chicago, Illinois"},{"name":"Bioinformatics core, Center for Research Informatics, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Stadnik","sequence":"additional","affiliation":[{"name":"Neurovascular Surgery Program, Department of Surgery, Section of Neurosurgery, University of Chicago Medicine and Biological Sciences, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1300-6845","authenticated-orcid":false,"given":"Robert","family":"Shenkar","sequence":"additional","affiliation":[{"name":"Neurovascular Surgery Program, Department of Surgery, Section of Neurosurgery, University of Chicago Medicine and Biological Sciences, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Hobson","sequence":"additional","affiliation":[{"name":"Neurovascular Surgery Program, Department of Surgery, Section of Neurosurgery, University of Chicago Medicine and Biological Sciences, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharbel","family":"Romanos","sequence":"additional","affiliation":[{"name":"Neurovascular Surgery Program, Department of Surgery, Section of Neurosurgery, University of Chicago Medicine and Biological Sciences, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Srinath","sequence":"additional","affiliation":[{"name":"Neurovascular Surgery Program, Department of Surgery, Section of Neurosurgery, University of Chicago Medicine and Biological Sciences, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Moore","sequence":"additional","affiliation":[{"name":"Neurovascular Surgery Program, Department of Surgery, Section of Neurosurgery, University of Chicago Medicine and Biological Sciences, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Lightle","sequence":"additional","affiliation":[{"name":"Neurovascular Surgery Program, Department of Surgery, Section of Neurosurgery, University of Chicago Medicine and Biological Sciences, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Shkoukani","sequence":"additional","affiliation":[{"name":"Neurovascular Surgery Program, Department of Surgery, Section of Neurosurgery, University of Chicago Medicine and Biological Sciences, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Akers","sequence":"additional","affiliation":[{"name":"Angioma Alliance, Norfolk, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Carroll","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, The University of Chicago Medicine and Biological Sciences, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A","family":"Christoforidis","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, The University of Chicago Medicine and Biological Sciences, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James I","family":"Koenig","sequence":"additional","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Lee","sequence":"additional","affiliation":[{"name":"Angioma Alliance, Norfolk, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Piedad","sequence":"additional","affiliation":[{"name":"Neurovascular Surgery Program, Department of Surgery, Section of Neurosurgery, University of Chicago Medicine and Biological Sciences, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Anesthesia & Perioperative Care, University of California at San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly D","family":"Flemming","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1510-602X","authenticated-orcid":false,"given":"Issam A","family":"Awad","sequence":"additional","affiliation":[{"name":"Neurovascular Surgery Program, Department of Surgery, Section of Neurosurgery, University of Chicago Medicine and Biological Sciences, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3]]},"reference":[{"issue":"4","key":"bib1-20231011","first-page":"547","article-title":"Pathological heterogeneity of angiographically occult vascular malformations of the brain","volume":"33","author":"Robinson","year":"1993","journal-title":"Neurosurgery"},{"issue":"1","key":"bib2-20231011","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00006123-199901000-00020","article-title":"A comparison of the clinical profile of cavernous malformations with and without associated venous malformations","volume":"44","author":"Abdulrauf","year":"1999","journal-title":"Neurosurgery"},{"issue":"6","key":"bib3-20231011","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1227\/01.NEU.0000249188.38409.03","article-title":"Spectrum of genotype and clinical manifestations in cerebral cavernous malformations","volume":"59","author":"Gault","year":"2006","journal-title":"Neurosurgery"},{"issue":"5","key":"bib4-20231011","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/ddn430","article-title":"Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis","volume":"18","author":"Akers","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"4","key":"bib5-20231011","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/01.STR.0000157586.20479.fd","article-title":"Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion","volume":"36","author":"Gault","year":"2005","journal-title":"Stroke"},{"issue":"16","key":"bib6-20231011","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1093\/hmg\/ddu153","article-title":"Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis","volume":"23","author":"McDonald","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"5","key":"bib7-20231011","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/neuros\/nyx091","article-title":"Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the angioma alliance scientific advisory board clinical experts panel","volume":"80","author":"Akers","year":"2017","journal-title":"Neurosurgery"},{"issue":"3","key":"bib8-20231011","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1474-4422(12)70004-2","article-title":"Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study","volume":"11","author":"Al-Shahi Salman","year":"2012","journal-title":"Lancet Neurol"},{"issue":"2","key":"bib9-20231011","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1474-4422(15)00303-8","article-title":"Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data","volume":"15","author":"Horne","year":"2016","journal-title":"Lancet Neurol"},{"issue":"12","key":"bib10-20231011","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1161\/STROKEAHA.108.515544","article-title":"Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma alliance scientific advisory board","volume":"39","author":"Al-Shahi Salman","year":"2008","journal-title":"Stroke"},{"issue":"4","key":"bib11-20231011","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/neuros\/nyy108","article-title":"Trial readiness in cavernous angiomas with symptomatic hemorrhage (CASH)","volume":"84","author":"Polster","year":"2019","journal-title":"Neurosurgery"},{"issue":"6","key":"bib12-20231011","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/neuros\/nyy539","article-title":"Atorvastatin treatment of cavernous angiomas with symptomatic hemorrhage exploratory proof of concept (AT CASH EPOC) trial","volume":"85","author":"Polster","year":"2019","journal-title":"Neurosurgery"},{"issue":"1","key":"bib13-20231011","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/cpt.136","article-title":"Biomarker qualification: toward a multiple stakeholder framework for biomarker development, regulatory acceptance, and utilization","volume":"98","author":"Amur","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"bib14-20231011","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2217\/bmm.15.90","article-title":"Building a roadmap to biomarker qualification: challenges and opportunities","volume":"9","author":"Amur","year":"2015","journal-title":"Biomark Med"},{"issue":"2","key":"bib15-20231011","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11481-016-9670-0","article-title":"B-Cell depletion reduces the maturation of cerebral cavernous malformations in murine models","volume":"11","author":"Shi","year":"2016","journal-title":"J Neuroimmune Pharmacol"},{"issue":"5","key":"bib16-20231011","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/CIRCRESAHA.110.217257","article-title":"Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis","volume":"107","author":"Brutsch","year":"2010","journal-title":"Circ Res"},{"issue":"28","key":"bib17-20231011","doi-asserted-by":"crossref","first-page":"12640","DOI":"10.1073\/pnas.1000132107","article-title":"Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling","volume":"107","author":"Wustehube","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"bib18-20231011","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jocn.2016.12.023","article-title":"Co-expression of tissue factor and IL-6 in immature endothelial cells of cerebral cavernous malformations","volume":"37","author":"Noshiro","year":"2017","journal-title":"J Clin Neurosci"},{"issue":"1","key":"bib19-20231011","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2045-8118-9-23","article-title":"Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation","volume":"9","author":"Luissint","year":"2012","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"bib20-20231011","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1159\/000343302","article-title":"C-reactive protein increases BBB permeability: implications for obesity and neuroinflammation","volume":"30","author":"Hsuchou","year":"2012","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"bib21-20231011","doi-asserted-by":"crossref","first-page":"a029322","DOI":"10.1101\/cshperspect.a029322","article-title":"Vascular endothelial (VE)-Cadherin, endothelial adherens junctions, and vascular disease","volume":"10","author":"Lampugnani","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"bib22-20231011","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/01616412.1995.11740286","article-title":"Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: preliminary observations and working hypothesis","volume":"17","author":"Robinson","year":"1995","journal-title":"Neurol Res"},{"issue":"1","key":"bib23-20231011","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/STROKEAHA.116.015013","article-title":"RhoA kinase inhibition with fasudil versus simvastatin in murine models of cerebral cavernous malformations","volume":"48","author":"Shenkar","year":"2017","journal-title":"Stroke"},{"issue":"2","key":"bib24-20231011","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nm.1911","article-title":"The cerebral cavernous malformation signaling pathway promotes vascular integrity via rho GTPases","volume":"15","author":"Whitehead","year":"2009","journal-title":"Nat Med"},{"issue":"8","key":"bib25-20231011","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCRESAHA.117.309930","article-title":"Deregulated TGF-beta\/BMP signaling in vascular malformations","volume":"121","author":"Cunha","year":"2017","journal-title":"Circ Res"},{"issue":"3","key":"bib26-20231011","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2217\/bmm.15.118","article-title":"Peripheral plasma vitamin d and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease","volume":"10","author":"Girard","year":"2016","journal-title":"Biomark Med"},{"issue":"3","key":"bib27-20231011","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.114.010403","article-title":"Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation","volume":"131","author":"Gibson","year":"2015","journal-title":"Circulation"},{"issue":"Pt B","key":"bib28-20231011","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biocel.2016.09.011","article-title":"Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: two sides of the same coin","volume":"81","author":"Retta","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"bib29-20231011","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2045-8118-11-18","article-title":"Vascular disruption and blood-brain barrier dysfunction in intracerebral hemorrhage","volume":"11","author":"Keep","year":"2014","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"bib30-20231011","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.18632\/oncotarget.23518","article-title":"Arsenic exposure assists ccm3 genetic polymorphism in elevating blood pressure","volume":"9","author":"Gao","year":"2018","journal-title":"Oncotarget"},{"issue":"10","key":"bib31-20231011","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.STR.0000141932.44613.b1","article-title":"Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations","volume":"35","author":"Pawlikowska","year":"2004","journal-title":"Stroke"},{"issue":"2","key":"bib32-20231011","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jocn.2009.06.008","article-title":"Expressions of angiogenesis associated matrix metalloproteinases and extracellular matrix proteins in cerebral vascular malformations","volume":"17","author":"Bicer","year":"2010","journal-title":"J Clin Neurosci"},{"issue":"6","key":"bib33-20231011","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000369200","article-title":"Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity","volume":"38","author":"Choquet","year":"2014","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"bib34-20231011","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/archneur.60.11.1613","article-title":"Cerebral cavernous malformations with dynamic and progressive course: correlation study with vascular endothelial growth factor","volume":"60","author":"Jung","year":"2003","journal-title":"Arch Neurol"},{"issue":"1","key":"bib35-20231011","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12975-017-0561-3","article-title":"Plasma biomarkers of inflammation reflect seizures and hemorrhagic activity of cerebral cavernous malformations","volume":"9","author":"Girard","year":"2018","journal-title":"Transl Stroke Res"},{"issue":"1","key":"bib36-20231011","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.21710","article-title":"Soluble endoglin modulates aberrant cerebral vascular remodeling","volume":"66","author":"Chen","year":"2009","journal-title":"Ann Neurol"},{"issue":"4","key":"bib37-20231011","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1294-345","article-title":"Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1","volume":"8","author":"McAllister","year":"1994","journal-title":"Nat Genet"},{"issue":"7","key":"bib38-20231011","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/jir.2014.0188","article-title":"Interferon-gamma increases endothelial permeability by causing activation of p38 MAP kinase and actin cytoskeleton alteration","volume":"35","author":"Ng","year":"2015","journal-title":"J Interferon Cytokine Res"},{"issue":"4","key":"bib39-20231011","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm1742","article-title":"Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability","volume":"14","author":"Jones","year":"2008","journal-title":"Nat Med"},{"issue":"12","key":"bib40-20231011","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/CIRCRESAHA.118.312680","article-title":"Plasma biomarkers of inflammation and angiogenesis predict cerebral cavernous malformation symptomatic hemorrhage or lesional growth","volume":"122","author":"Girard","year":"2018","journal-title":"Circ Res"},{"issue":"12","key":"bib41-20231011","doi-asserted-by":"crossref","first-page":"e128577","DOI":"10.1172\/jci.insight.128577","article-title":"Biomarkers of cavernous angioma with symptomatic hemorrhage","volume":"4","author":"Lyne","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"bib42-20231011","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of microRNA function in animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"bib43-20231011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40291-016-0239-7","article-title":"Applications of extracellular RNAs in oncology","volume":"21","author":"Thompson","year":"2017","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"bib44-20231011","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/STROKEAHA.113.003578","article-title":"MicroRNA-18a improves human cerebral arteriovenous malformation endothelial cell function","volume":"45","author":"Ferreira","year":"2014","journal-title":"Stroke"},{"issue":"3","key":"bib45-20231011","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.25015","article-title":"MicroRNA-137 and microRNA-195* inhibit vasculogenesis in brain arteriovenous malformations","volume":"82","author":"Huang","year":"2017","journal-title":"Ann Neurol"},{"issue":"2","key":"bib46-20231011","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/STROKEAHA.113.003548","article-title":"Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations","volume":"45","author":"Mikati","year":"2014","journal-title":"Stroke"},{"issue":"3","key":"bib47-20231011","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2014.97","article-title":"Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations","volume":"17","author":"Shenkar","year":"2015","journal-title":"Genet Med"},{"issue":"10","key":"bib48-20231011","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/jcbfm.2015.98","article-title":"Vascular permeability in cerebral cavernous malformations","volume":"35","author":"Mikati","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"bib49-20231011","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12975-013-0285-y","article-title":"Dynamic contrast-enhanced MRI evaluation of cerebral cavernous malformations","volume":"4","author":"Hart","year":"2013","journal-title":"Transl Stroke Res"},{"issue":"1","key":"bib50-20231011","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3171\/2016.5.JNS16687","article-title":"Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations","volume":"127","author":"Girard","year":"2017","journal-title":"J Neurosurg"},{"issue":"4","key":"bib51-20231011","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/jmri.25831","article-title":"Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage","volume":"47","author":"Zeineddine","year":"2018","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"bib52-20231011","doi-asserted-by":"crossref","first-page":"e126167","DOI":"10.1172\/jci.insight.126167","article-title":"Comprehensive transcriptome analysis of cerebral cavernous malformation across multiple species and genotypes","volume":"4","author":"Koskimaki","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"bib53-20231011","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40478-019-0789-0","article-title":"Transcriptome clarifies mechanisms of lesion genesis versus progression in models of ccm3 cerebral cavernous malformations","volume":"7","author":"Koskimaki","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"bib54-20231011","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nm.4169","article-title":"Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation","volume":"22","author":"Zhou","year":"2016","journal-title":"Nat Med"},{"issue":"7455","key":"bib55-20231011","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature12207","article-title":"EndMT contributes to the onset and progression of cerebral cavernous malformations","volume":"498","author":"Maddaluno","year":"2013","journal-title":"Nature"},{"issue":"7654","key":"bib56-20231011","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature22075","article-title":"Endothelial TLR4 and the microbiome drive cerebral cavernous malformations","volume":"545","author":"Tang","year":"2017","journal-title":"Nature"},{"issue":"7597","key":"bib57-20231011","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature17178","article-title":"Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2\/4 signalling","volume":"532","author":"Zhou","year":"2016","journal-title":"Nature"},{"issue":"11","key":"bib58-20231011","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1084\/jem.20171178","article-title":"Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations","volume":"214","author":"Lopez-Ramirez","year":"2017","journal-title":"J Exp Med"},{"issue":"2","key":"bib59-20231011","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000485227","article-title":"Human malformation syndromes of defective GLI: opposite phenotypes of 2q14.2 (GLI2) and 7p14.2 (GLI3) microdeletions and a GLIA\/R balance model","volume":"153","author":"Niida","year":"2017","journal-title":"Cytogenet Genome Res"},{"issue":"3","key":"bib60-20231011","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1182\/blood-2018-06-856062","article-title":"Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice","volume":"133","author":"Lopez-Ramirez","year":"2019","journal-title":"Blood"},{"issue":"1","key":"bib61-20231011","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2045-824X-4-12","article-title":"Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability","volume":"4","author":"Krouwer","year":"2012","journal-title":"Vascular cell"},{"key":"bib62-20231011","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12979-015-0029-9","article-title":"Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment","volume":"12","author":"Elahy","year":"2015","journal-title":"Immun Ageing"},{"issue":"3","key":"bib63-20231011","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mvr.2009.06.009","article-title":"Reproductive age-related changes in the blood brain barrier: expression of IgG and tight junction proteins","volume":"78","author":"Bake","year":"2009","journal-title":"Microvasc Res"},{"issue":"4","key":"bib64-20231011","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1189\/jlb.0710432","article-title":"Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte-endothelial interactions","volume":"89","author":"Rossi","year":"2011","journal-title":"J Leukoc Biol"},{"issue":"12","key":"bib65-20231011","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm.1878","article-title":"A role for leukocyte-endothelial adhesion mechanisms in epilepsy","volume":"14","author":"Fabene","year":"2008","journal-title":"Nat Med"},{"issue":"6","key":"bib66-20231011","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nm.2759","article-title":"ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1","volume":"18","author":"Avraham-Davidi","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"bib67-20231011","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41467-020-16436-w","article-title":"Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma","volume":"11","author":"Polster","year":"2020","journal-title":"Nat Commun"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/article-pdf\/88\/3\/686\/39649616\/nyaa478.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyaa478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:59:53Z","timestamp":1786121993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyaa478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1093\/neuros\/nyaa478","relation":{},"ISSN":["0148-396X","1524-4040"],"issn-type":[{"value":"0148-396X","type":"print"},{"value":"1524-4040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]}}}